Massachusetts Financial Services’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-950,594
| Closed | -$10.1M | – | 879 |
|
|
2022
Q3 | $10.1M | Sell |
950,594
-376,499
| -28% | -$4.01M | ﹤0.01% | 613 |
|
|
2022
Q2 | $10.8M | Sell |
1,327,093
-9,657
| -0.7% | -$78.6K | ﹤0.01% | 603 |
|
|
2022
Q1 | $9.57M | Buy |
1,336,750
+36,709
| +3% | +$263K | ﹤0.01% | 639 |
|
|
2021
Q4 | $22.3M | Buy |
1,300,041
+404,181
| +45% | +$6.92M | 0.01% | 594 |
|
|
2021
Q3 | $20.6M | Sell |
895,860
-80,069
| -8% | -$1.84M | 0.01% | 612 |
|
|
2021
Q2 | $35.6M | Buy |
+975,929
| New | +$35.6M | 0.01% | 554 |
|